FDA approves Progenics' treatment for rare adrenal gland tumors

The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc's treatment for two types of rare adrenal gland tumors, making it the first drug approved in the United States for this use.

from Reuters: Health https://ift.tt/2uZcG0A
via IFTTT

• Tweet
• Share
• Share
• Share
• Share